In Canada, psychedelics re-emerge in treatment of depression
When it comes to using psychedelics for therapeutic reasons, there is mounting interest from researchers and investors, as well as a public push to reconsider bans on the drugs.
Why the vaccine safety numbers are still fuzzy
If there is a connection between the Johnson & Johnson vaccine and a rare clotting syndrome, new cases are likely to emerge now that the word is out.
How China fell behind after passing up a vaccine opportunity
In the early stages of the pandemic, China and other Asian nations failed to jump on mRNA tech, which has become the breakout star of the COVID-19 era.
Vaccine blood-clot side effect puts focus on immune reaction
Health officials are exploring whether and how an immune reaction may occur in people who have received vaccines made by AstraZeneca and Johnson & Johnson.
U.S. calls for pause on Johnson & Johnson vaccine after clotting cases
The concerns about the shot mirror those about AstraZeneca’s, which European regulators began investigating last month after some recipients developed blood clots.
Asian nations scale back AstraZeneca rollout amid safety woes
The moves may delay protection for the region amid concerns that the shot could trigger a rare and potentially deadly blood clotting condition.
China considering mixing COVID-19 vaccines to boost protection rate
The move comes after Beijing's top disease official said the country's available vaccines "don't have very high rates of protection."
Japanese drug regulator to fast-track any modified vaccines to fight variants
Vaccines targeting new variants of the coronavirus won't require domestic clinical trials if the production process and handling of the shots are similar to those of the original.
More countries restrict use of AstraZeneca shot as world scramble for vaccines
Britain sought Thursday to quell fears over the jab, saying the potential side effects were extremely rare — and the risk of getting seriously sick from COVID-19 was far greater.
Japanese researchers finds some drugs effective against coronavirus
The team has found some existing medical agents effective in inhibiting RNA viruses through an experiment using stem cells.
AstraZeneca U.K. vaccine trial in children paused as clot link probed
The news is the latest blow to the firm, which has faced controversy over its failure to deliver doses to the European Union, and over the jab's efficacy and safety profile.
One of Taiwan’s few allies weighs embracing China for vaccines
As poor nations struggle to get their hands on vaccines, a thinly-populated South American country finds its chances linked to its unexpected role in tensions between the U.S. and China.
